Cancer risk following treatment with non-contraceptive estrogens was studied in a population-based cohort of 23,244 women. Complete follow-up for an average of 6.7 years revealed 1,087 incident cancers versus 962.5 expected (relative risk/RR/ = 1.13; 95% confidence interval 1.10-1.20). We confirmed
Design of an ideal hormone replacement therapy for women
β Scribed by Debra A. Tonetti; V. Craig Jordan
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 482 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0899-1987
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Increasing use of HRT over the last 2 decades could have contributed to the increasing incidence of cancer in women. Our aim was to investigate the relation between use of HRT and risk of hormoneβdependent cancers in a Norwegian cohort of women. The Norwegian Women and Cancer (NOWAC) st
## Abstract We examined the relation between the use of hormone replacement therapy (HRT) and the incidence of central nervous system (CNS) tumours in a large prospective study of 1,147,894 postmenopausal women. Women were aged 56.6 years on average at entry, and HRT use was recorded at recruitment
## Abstract Evidence from epidemiologic studies suggests a possible role of exogenous and endogenous hormones in colorectal carcinogenesis in women. However, with respect to exogenous hormones, in contrast to hormone replacement therapy, few cohort studies have examined oral contraceptive use in re